Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study

BACKGROUND The diagnosis of hypertension has traditionally been based on blood-pressure measurements in the clinic, but home and ambulatory measurements better correlate with cardiovascular outcome, and ambulatory monitoring is more accurate than both clinic and home monitoring in diagnosing hypertension. We aimed to compare the cost-effectiveness of different diagnostic strategies for hypertension. METHODS We did a Markov model-based probabilistic cost-effectiveness analysis. We used a hypothetical primary-care population aged 40 years or older with a screening blood-pressure measurement greater than 140/90 mm Hg and risk-factor prevalence equivalent to the general population. We compared three diagnostic strategies-further blood pressure measurement in the clinic, at home, and with an ambulatory monitor-in terms of lifetime costs, quality-adjusted life years, and cost-effectiveness. FINDINGS Ambulatory monitoring was the most cost-effective strategy for the diagnosis of hypertension for men and women of all ages. It was cost-saving for all groups (from -£56 [95% CI -105 to -10] in men aged 75 years to -£323 [-389 to -222] in women aged 40 years) and resulted in more quality-adjusted life years for men and women older than 50 years (from 0·006 [0·000 to 0·015] for women aged 60 years to 0·022 [0·012 to 0·035] for men aged 70 years). This finding was robust when assessed with a wide range of deterministic sensitivity analyses around the base case, but was sensitive if home monitoring was judged to have equal test performance to ambulatory monitoring or if treatment was judged effective irrespective of whether an individual was hypertensive. INTERPRETATION Ambulatory monitoring as a diagnostic strategy for hypertension after an initial raised reading in the clinic would reduce misdiagnosis and save costs. Additional costs from ambulatory monitoring are counterbalanced by cost savings from better targeted treatment. Ambulatory monitoring is recommended for most patients before the start of antihypertensive drugs. FUNDING National Institute for Health Research and the National Institute for Health and Clinical Excellence.

[1]  L. Kalra,et al.  The Economic Burden of Stroke in the United Kingdom , 2012, PharmacoEconomics.

[2]  G. Bergus,et al.  Influence of Patient Characteristics on Success of Ambulatory Blood Pressure Monitoring , 2008, Pharmacotherapy.

[3]  D. Mant,et al.  Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure , 2002, BMJ : British Medical Journal.

[4]  J F Potter,et al.  Extract from : , 2009 .

[5]  G. Stergiou,et al.  Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? , 2005, American journal of hypertension.

[6]  R. Cooper,et al.  Hypertension Treatment and Control in Five European Countries, Canada, and the United States , 2004, Hypertension.

[7]  M. Schroll,et al.  Survival and cause of death after myocardial infarction: the Danish MONICA study. , 2001, Journal of clinical epidemiology.

[8]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[9]  Milton C. Weinstein,et al.  Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level , 2005, Circulation.

[10]  F. Cuccurullo,et al.  'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. , 1995, European heart journal.

[11]  Y. Dundar,et al.  Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. , 2011, Health technology assessment.

[12]  G Chatellier,et al.  Is "isolated home" hypertension as opposed to "isolated office" hypertension a sign of greater cardiovascular risk? , 2001, Archives of internal medicine.

[13]  Ben Ewald,et al.  Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian general practice , 2002, The Medical journal of Australia.

[14]  Tine Willum Hansen,et al.  Ambulatory Blood Pressure and Mortality: A Population-Based Study , 2005, Hypertension.

[15]  L. Krakoff.  Cost-Effectiveness of Ambulatory Blood Pressure: A Reanalysis , 2006, Hypertension.

[16]  L. Wilhelmsen,et al.  Natural history of myocardial infarction and angina pectoris in a general population sample of middle‐aged men: a 16‐year follow‐up of the Primary Prevention Study, Göteborg, Sweden , 1998, Journal of internal medicine.

[17]  Shigeru Hisamichi,et al.  Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population‐based observation in Ohasama, Japan , 1998, Journal of hypertension.

[18]  Julia A. Critchley,et al.  Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2004 .

[19]  J. Robson,et al.  Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease , 2007, Heart.

[20]  N. Roberts,et al.  Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review , 2011, BMJ : British Medical Journal.

[21]  L. Ruilope,et al.  Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. , 1998, Hypertension.

[22]  K. Asayama,et al.  Use of 2003 European Society of Hypertension-European Society of Cardiology guidelines for predicting stroke using self-measured blood pressure at home: the Ohasama study. , 2005, European heart journal.

[23]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[24]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[25]  William Branch,et al.  Clinical Inertia , 2001, Annals of Internal Medicine.

[26]  S. Ward,et al.  A systematic review and economic evaluation of statins for the prevention of coronary events. , 2007, Health technology assessment.

[27]  J. Whitworth,et al.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension , 2003, Journal of hypertension.

[28]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.

[29]  T. Ohkubo,et al.  Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. , 1996, Blood pressure monitoring.

[30]  S. Haneuse,et al.  On the Assessment of Monte Carlo Error in Simulation-Based Statistical Analyses , 2009, The American statistician.

[31]  G. Parati,et al.  Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. , 1991, Journal of hypertension.

[32]  Giuseppe Andronico,et al.  Value of Home Blood Pressures as Predictor of Target Organ Damage in Mild Arterial Hypertension , 2002, Journal of cardiovascular risk.

[33]  T. Horio,et al.  Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[34]  D. Sackett,et al.  Effects of labelling on income, work and social function among hypertensive employees. , 1984, Journal of chronic diseases.

[35]  M. Kikuya,et al.  Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study , 2000, Journal of hypertension.

[36]  Gianfranco Parati,et al.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .

[37]  Sc Prospective,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002 .

[38]  N J Wald,et al.  A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.

[39]  M. Sculpher,et al.  Decision Modelling for Health Economic Evaluation , 2006 .

[40]  J Bamford,et al.  Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. , 1990, Stroke.

[41]  Gretchen A. Stevens,et al.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants , 2011, The Lancet.

[42]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[43]  A. Rodgers,et al.  Global burden of blood-pressure-related disease, 2001 , 2008, The Lancet.

[44]  P. Verdecchia.  Reference values for ambulatory blood pressure and self-measured blood pressure based on prospective outcome data , 2001, Blood pressure monitoring.

[45]  M. Davidsen,et al.  Long-Term Survival and Causes of Death After Stroke , 2001, Stroke.

[46]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[47]  K. Asayama,et al.  Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension , 2008, Journal of hypertension.

[48]  Alice Stanton,et al.  Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study , 2005, Hypertension.